To confirm the hypothesis that EGF-stimulated MAP-kinase ERK1/2 is involved in regulation of functioning of the microtubule (MT) system, the influence of two widely used ERK1/2 inhibitors, U0126 and PD98059, on tubulin cytoskeleton organization in interphase HeLa cells during EGF receptor endocytosis has been investigated. It was found that addition of U0126 or PD98059 to cells that are not stimulated with EGF for 30 min had no influence on the radially organized MT system. However, in the case of U0126 addition before EGF endocytosis stimulation, 15 min after this stimulation, a decrease in MT number per cell was seen, which was followed by complete MT depolymerization for 60–90 min. If endocytosis was stimulated in the presence of PD98059, only a very small decrease in MT number, mainly from their minus ends, could be detected. At the same time, MT regions close to plasma membrane became stabilized, which was proven by increase in tubulin acetylation level. This was characteristic of all periods of the experiment. It was also found that inhibitors affected endocytosis dynamics of EGF-receptor complexes. Quantitative analysis has shown that, upon endocytosis stimulation in the presence of U0126, more endosomes were formed than in the case of control cells and their number did not change significantly during the experiment. All these endosomes were localized peripherally. The effect of PD98059 resulted in the formation of fewer endosomes than in control, but they exhibited very slow clusterization in the juxtanuclear area in spite of the presence of a few intact MTs. Both inhibitors decreased EGFR colocalization with the early endosomal marker EEA1, which indicates a delay in endosome fusion and maturation. The inhibitors were also shown to differently affect the phospho-ERK 1 and 2 forms: U0126 completely inhibited phospho-ERK1 and 2, while, in the presence of PD98059, the two ERK forms exhibited a sharp transient activation at 15 min, while only phospho-ERK2 could be detected after 60 min of endocytosis. In both cases, the dynamics of MAP-kinase activation was significantly different from that in control. Our results suggest that the EGF-stimulated MAP-kinase pathway plays a role in cytoskeleton regulation. At the same time, they exhibit nonequivalency of the two widely used inhibitors in relation to not only MAP-kinase activity, but also to such interdependent processes as changes in cytoskeleton organization and signaling receptor endocytosis.
Read full abstract